Yvonne Greenstreet
Chief Executive Officer
Replay available
Alnylam Pharmaceuticals, Inc. (ALNY) Q2 2025 Earnings Call
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Q2 2025 earnings conference call, held 2025-07-31. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bova Tanguilar
Chief Commercial Officer
Krish Pagard
Chief Research and Development Officer
Jeff Fulton
Chief Financial Officer
Richter Salvi
Analyst, Goldman Sachs
Tazeen Ahmad
Analyst, Bank of America
Marie Raycroft
Analyst, Jefferies
Paul Mattis
Analyst, Stifel
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Alnylam Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.095 With me today are Yvonne Greenstreet, Chief Executive Officer, Bova Tanguilar, Chief 00:00:04.095 -- 00:00:08.620 Commercial Officer, Krish Pagard, Chief Research and Development Officer, and Jeff Fulton, 00:00:08.620 -- 00:00:12.865 Chief Financial Officer. For those of you participating via conference call, the accompanying 00:00:12.865 -- 00:00:17.310 slides can be accessed by going to the events section of the investors page of our website, 00:00:17.310 -- 00:00:19.152 investors.onilam.com 00:00:19.152 -- 00:00:24.297 slash events. During today's call, as outlined in slide two, Yvonne will offer introductory 00:00:24.297 -- 00:00:28.882 remarks and provide some general context. Tova will provide an update on our global commercial 00:00:28.882 -- 00:00:33.399 progress. Bush will review pipeline updates and clinical progress, and Jeff will review 00:00:33.399 -- 00:00:37.623 our financials and guidance, followed by a summary of upcoming milestones before we open 00:00:37.623 -- 00:00:39.885 the call to your questions. 00:00:39.885 -- 00:00:43.669 I'd like to remind you that this call will contain remarks concerning Alnylam's future 00:00:43.669 -- 00:00:47.333 expectations, plans, and prospects, which constitute forward-looking statements for the 00:00:47.333 -- 00:00:50.976 purposes of the safe harbor provision under the Private Securities Litigation Reform 00:00:50.976 -- 00:00:53.198 Act of 1995. 00:00:53.198 -- 00:00:56.902 Actual results may differ materially from those indicated by these forward-looking statements 00:00:56.902 -- 00:01:00.901 as a result of various important factors, including those discussed in our most recent 00:01:00.901 -- 00:01:06.269 periodic report on file of the SEC. In addition, any forward-looking...